Paulus Holdings agreed to acquire Alto Pharmacy in a deal valuing the digital pharmacy business at $1 billion to $1.5 billion, per Bloomberg. The deal positions Paulus, backer of LetsGetChecked-owned Truepill, for a digital pharmacy roll-up at a time when solo startups in the sector have struggled with low margins. Alto, backed by SoftBank Group, was last valued at $786 million, per PitchBook — a steep decline from the $1.8 billion valuation it garnered in 2020. Times have changed. Digital pharmacy startups are now facing significant challenges, including a collapsing direct-to-consumer health market, insufficient infrastructure and difficulty customizing platforms built on legacy code, Axios has reported.
Read the full article: Paulus Reportedly Agrees to Buy SoftBank-Backed Alto Pharmacy //
Source: https://www.axios.com/pro/health-tech-deals/2025/03/27/paulus-reportedly-buying-alto-pharmacy-softbank